— Know what they know.
Not Investment Advice

ATNX NASDAQ

Athenex, Inc.
1W: -42.1% 1M: -82.5% 3M: -92.8% 1Y: -97.9% 3Y: -99.9% 5Y: -99.9%
$0.20
Last traded 2023-05-24 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $2.3M mcap · 7M float · 3.93% daily turnover

Cash Flow Trends

Operating Cash Flow
-$75M +47.3% ▲
Capital Expenditures
$2M +80.4% ▲
5Y CAGR: -21.7%
Free Cash Flow
-$77M +49.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$2M -2097.5% ▼
Net Change in Cash
-$16M +53.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$129M-$126M-$148M-$194M-$99M
Depreciation & Amort.$3M$4M$4M$5M$2M
Stock-Based Comp.$11M$10M$11M$9M$6M
Change in Working Capital-$27M$13M-$20M-$24M$12M
Other Non-Cash Items$33M$1M$22M$73M$4M
Operating Cash Flow-$109M-$97M-$131M-$142M-$75M
— Investing Activities —
Capital Expenditures-$3M-$18M-$13M-$11M-$2M
Acquisitions (Net)$110K$853K$214K$2M$0
Investment Purchases-$113M-$75M-$162M-$69M-$9M
Investment Sales$68M$99M$56M$198M$19M
Other Investing-$110K$0-$214K-$15M$50M
Investing Cash Flow-$49M$7M-$119M$105M$58M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0-$79K-$2M
Dividends Paid$0$0$0$0$0
Other Financing$169M$167M$209M$2M$2M
Financing Cash Flow$169M$167M$209M$2M$2M
Net Change in Cash$11M$78M-$42M-$34M-$16M
Cash End of Period$50M$128M$86M$52M$36M
Free Cash Flow-$113M-$115M-$145M-$153M-$77M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms